Malaria plan under scrutiny

摘要

Is showering a country with low-cost malaria drugs the best way to stem the disease? As a US$463-million pilot programme to test the strategy in seven African countries winds down, public-health experts are questioning whether the approach makes sense given shrinking global health budgets and a steady decline in malaria prevalence.